Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Papanin Putsathit

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
European Journal of Medicinal Chemistry|March 5, 2019
Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles: synthesis, antibacterial evaluation and preliminary mechanism of action studiesAndrew J Tague, Papanin Putsathit, Katherine A Hammer, et al.
Journal of Applied Microbiology|December 11, 2021
Whole-genome sequencing links Clostridium (Clostridioides) difficile in a single hospital to diverse environmental sources in the communitySu-Chen Lim, Deirdre A Collins, Korakrit Imwattana, et al.
ACS Omega|March 7, 2022
Development of 1,2,4-Oxadiazole Antimicrobial Agents to Treat Enteric Pathogens within the Gastrointestinal TractNoel P Pitcher, Jitendra R Harjani, Yichao Zhao, et al.
European Journal of Medicinal Chemistry|March 23, 2019
Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles targeting Clostridioides (Clostridium) difficile: Synthesis, antibacterial evaluation and an in vivo C. difficile infection modelAndrew J Tague, Papanin Putsathit, Melanie L Hutton, et al.
Antibiotics (Basel, Switzerland)|August 27, 2021
Cationic Peptidomimetic Amphiphiles Having a <i>N</i>-Aryl- or <i>N</i>-Naphthyl-1,2,3-Triazole Core Structure Targeting <i>Clostridioides</i> (<i>Clostridium</i>) <i>difficile</i>: Synthesis, Antibacterial Evaluation, and an In Vivo <i>C. difficile</i> Infection ModelMuni Kumar Mahadari, Sreenu Jennepalli, Andrew J Tague, et al.
Journal of Clinical Microbiology|August 28, 2020
Laboratory-Based Surveillance of Clostridium difficile Infection in Australian Health Care and Community Settings, 2013 to 2018Stacey Hong, Papanin Putsathit, Narelle George, et al.
The Journal of Antimicrobial Chemotherapy|April 25, 2021
Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18Papanin Putsathit, Stacey Hong, Narelle George, et al.
Microbial Genomics|May 8, 2024
Defining the phylogenetics and resistome of the major <i>Clostridioides difficile</i> ribotypes circulating in AustraliaKeeley O'Grady, Stacey Hong, Papanin Putsathit, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
European Journal of Medicinal Chemistry|March 5, 2019
Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles: synthesis, antibacterial evaluation and preliminary mechanism of action studiesAndrew J Tague, Papanin Putsathit, Katherine A Hammer, et al.
Journal of Applied Microbiology|December 11, 2021
Whole-genome sequencing links Clostridium (Clostridioides) difficile in a single hospital to diverse environmental sources in the communitySu-Chen Lim, Deirdre A Collins, Korakrit Imwattana, et al.
ACS Omega|March 7, 2022
Development of 1,2,4-Oxadiazole Antimicrobial Agents to Treat Enteric Pathogens within the Gastrointestinal TractNoel P Pitcher, Jitendra R Harjani, Yichao Zhao, et al.
European Journal of Medicinal Chemistry|March 23, 2019
Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles targeting Clostridioides (Clostridium) difficile: Synthesis, antibacterial evaluation and an in vivo C. difficile infection modelAndrew J Tague, Papanin Putsathit, Melanie L Hutton, et al.
Antibiotics (Basel, Switzerland)|August 27, 2021
Cationic Peptidomimetic Amphiphiles Having a <i>N</i>-Aryl- or <i>N</i>-Naphthyl-1,2,3-Triazole Core Structure Targeting <i>Clostridioides</i> (<i>Clostridium</i>) <i>difficile</i>: Synthesis, Antibacterial Evaluation, and an In Vivo <i>C. difficile</i> Infection ModelMuni Kumar Mahadari, Sreenu Jennepalli, Andrew J Tague, et al.
Journal of Clinical Microbiology|August 28, 2020
Laboratory-Based Surveillance of Clostridium difficile Infection in Australian Health Care and Community Settings, 2013 to 2018Stacey Hong, Papanin Putsathit, Narelle George, et al.
The Journal of Antimicrobial Chemotherapy|April 25, 2021
Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18Papanin Putsathit, Stacey Hong, Narelle George, et al.
Microbial Genomics|May 8, 2024
Defining the phylogenetics and resistome of the major <i>Clostridioides difficile</i> ribotypes circulating in AustraliaKeeley O'Grady, Stacey Hong, Papanin Putsathit, et al.
Pageof 3